Streetbeat News

Stock Prices

CGC

TLRY

Canopy Growth (NASDAQ:CGC) and Tilray (NASDAQ:TLRY) have initiated $250M At-The-Market (ATM) equity issuance programs, which allow for incremental share sales at current market prices, potentially reducing stock pressure compared to traditional equity issues. Canopy's stock fell 8.45% following the announcement, but the decline would have been steeper with a regular equity issue. Both companies trade at premiums to the group's market-to-tangible book value median, with Canopy showing better year-to-date performance due to its U.S. acquisitions.

Portfolio Pulse from Nicolás Jose Rodriguez

June 07, 2024 | 9:32 pm

CME

CME Group (NASDAQ:CME) has outperformed the market over the past 20 years with an average annual return of 10.9%, resulting in a $1000 investment growing to $7,861.20. The company currently has a market capitalization of $71.78 billion.

Portfolio Pulse from Benzinga Insights

June 07, 2024 | 9:31 pm

GDDY

GoDaddy shares are trading higher after it was announced the company will join the S&P 500.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 9:28 pm

CRWD

CrowdStrike shares are trading higher following the announcement that the company will join the S&P 500.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 9:28 pm

KKR

KKR & Co shares are trading higher after it was announced the company will join the S&P 500.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 9:28 pm

CEAD

CEA Industries' recent 13D filing reveals that 111 Equity Group LLC has acquired a 9.0% stake in the company as of June 3, 2024. This significant investment was reported in an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 9:26 pm

CRWD

GDDY

KKR

KKR, CrowdStrike, and GoDaddy are set to join the S&P 500, which could lead to increased investor interest and potential stock price movements.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 9:23 pm

NFLX

Netflix's shareholders did not approve a non-binding stockholder proposal titled 'Report On Netflix's Use Of Artificial Intelligence'.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 9:22 pm

DRMA

Dermata Therapeutics has entered into an At-The-Market (ATM) agreement with H.C. Wainwright, allowing the sale of up to $1.2 million of its common stock over time.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 9:22 pm

FDMT

4D Molecular Therapeutics (FDMT) has entered into a sales agreement with Leerink Partners, allowing the company to sell up to $250 million of common stock, as per an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 9:19 pm